11-64989731-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001300808.2(BATF2):c.-33C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,918 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001300808.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BATF2 | NM_138456.4 | c.223C>T | p.Arg75Trp | missense_variant | Exon 3 of 3 | ENST00000301887.9 | NP_612465.3 | |
BATF2 | NM_001300808.2 | c.-33C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 2 of 2 | NP_001287737.1 | |||
BATF2 | NM_001300807.2 | c.151C>T | p.Arg51Trp | missense_variant | Exon 2 of 2 | NP_001287736.1 | ||
BATF2 | NM_001300808.2 | c.-33C>T | 5_prime_UTR_variant | Exon 2 of 2 | NP_001287737.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152190Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248464Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134736
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461728Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 727172
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152190Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.223C>T (p.R75W) alteration is located in exon 3 (coding exon 3) of the BATF2 gene. This alteration results from a C to T substitution at nucleotide position 223, causing the arginine (R) at amino acid position 75 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at